Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 53.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26,915 shares of the biotechnology company’s stock after selling 31,270 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Axon Enterprise were worth $3,115,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of AXON. IFP Advisors Inc raised its holdings in Axon Enterprise by 36.8% in the 3rd quarter. IFP Advisors Inc now owns 364 shares of the biotechnology company’s stock worth $28,000 after purchasing an additional 98 shares during the period. SJS Investment Consulting Inc. acquired a new position in Axon Enterprise in the 3rd quarter worth about $30,000. Covestor Ltd raised its holdings in Axon Enterprise by 1,125.7% in the 1st quarter. Covestor Ltd now owns 429 shares of the biotechnology company’s stock worth $59,000 after purchasing an additional 394 shares during the period. Signaturefd LLC raised its holdings in Axon Enterprise by 27.8% in the 3rd quarter. Signaturefd LLC now owns 598 shares of the biotechnology company’s stock worth $69,000 after purchasing an additional 130 shares during the period. Finally, Nisa Investment Advisors LLC raised its holdings in Axon Enterprise by 56.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 696 shares of the biotechnology company’s stock worth $82,000 after purchasing an additional 251 shares during the period. Institutional investors and hedge funds own 75.62% of the company’s stock.

Get Axon Enterprise alerts:

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 71,499 shares of the stock in a transaction that occurred on Tuesday, January 17th. The stock was sold at an average price of $185.77, for a total value of $13,282,369.23. Following the completion of the transaction, the chief executive officer now directly owns 2,254,734 shares in the company, valued at $418,861,935.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Patrick W. Smith sold 1,300 shares of the firm’s stock in a transaction on Thursday, January 19th. The stock was sold at an average price of $185.06, for a total transaction of $240,578.00. Following the completion of the transaction, the chief executive officer now directly owns 2,279,570 shares in the company, valued at $421,857,224.20. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Patrick W. Smith sold 71,499 shares of the firm’s stock in a transaction on Tuesday, January 17th. The stock was sold at an average price of $185.77, for a total value of $13,282,369.23. Following the transaction, the chief executive officer now owns 2,254,734 shares of the company’s stock, valued at $418,861,935.18. The disclosure for this sale can be found here. Over the last three months, insiders sold 343,342 shares of company stock worth $64,743,588. Company insiders own 6.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on AXON. Northland Securities increased their target price on Axon Enterprise from $140.00 to $160.00 in a report on Wednesday, November 9th. Barclays increased their target price on Axon Enterprise from $177.00 to $222.00 and gave the company an “overweight” rating in a report on Thursday, March 2nd. Robert W. Baird increased their target price on Axon Enterprise from $200.00 to $237.00 and gave the company an “outperform” rating in a report on Wednesday, March 1st. JPMorgan Chase & Co. cut Axon Enterprise from an “overweight” rating to a “neutral” rating and set a $224.00 target price for the company. in a report on Thursday, March 2nd. Finally, Craig Hallum increased their target price on Axon Enterprise from $215.00 to $242.00 in a report on Wednesday, March 1st. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $217.50.

Axon Enterprise Trading Up 0.4 %

Shares of Axon Enterprise stock opened at $222.24 on Wednesday. The firm has a market capitalization of $16.19 billion, a price-to-earnings ratio of 108.94 and a beta of 0.92. Axon Enterprise, Inc. has a fifty-two week low of $82.49 and a fifty-two week high of $224.49. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.66 and a current ratio of 3.00. The stock has a 50 day moving average of $189.47 and a 200 day moving average of $161.97.

Axon Enterprise Profile

(Get Rating)

Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.

Featured Stories

• Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
• Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
• Market Gets “Powelled”: S&P 500 Confirms Resistance 
• Rivian Plummets, But Is This 2023’s Greatest Buying Opportunity?
• Ulta Insiders Hold Tight: Sell-Siders Buy 
• Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.